Entera Bio Ltd.
ENTX$85M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaJERUSALEM
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
ENTX News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
EB612 (EBP05)
Hypoparathyroidism
EBP05
Hypoparathyroidism
EnteraBio's Oral Parathyroid Hormone (1-34)
Hypoparathyroidism
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
EB612 (EBP05) | Phase 2 | Hypoparathyroidism | - | - |
EBP05 | Phase 2 | Hypoparathyroidism | - | - |
EnteraBio's Oral Parathyroid Hormone (1-34) | Phase 2 | Hypoparathyroidism | - | - |
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply